Skip to main content

Advertisement

SpringerLink
Log in

Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding Study of Platinum Originating from Dicycloplatin, a Novel Antitumor Supramolecule, in Rats and Dogs by ICP-MS

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Dicycloplatin, as a new antitumor supramolecule, was considered to have higher solubility and higher stability compared with carboplatin. The aim of the present study was to evaluate the pharmacokinetic characteristics of platinum originating from dicycloplatin. A rapid, sensitive, and specific method with inductively coupled plasma mass spectrometry (ICP-MS) has been developed for the determination of platinum in bio-samples. The study was performed in male rats and dogs at a single dose of 10 and 5 mg kg−1 separately by intravenous injection. Pharmacokinetic parameters were calculated by non-compartmental method, and the dose of platinum was used in the calculation of these parameters. Results showed that plasma concentrations of platinum began to decrease rapidly initially but decline slowly with a long terminal phase. The mean half-life was 27.39 and 100.98 and clearance was 0.77 and 0.08 L/h/kg for rats and dogs separately. Tissue distribution showed that platinum originating from dicycloplatin had a certain distribution in testis and prostate. Plasma protein binding proportion of platinum was increased with time. In conclusion, this research investigated the pharmacokinetic characteristics including plasma kinetics, tissue distribution, and plasma protein binding of platinum originating from dicycloplatin in rats and dogs in detail for the first time by ICP-MS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Rybak LP, Mukherjea D, Jajoo S, Ramkumar V (2009) Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 219:177–186

    Article  PubMed  CAS  Google Scholar 

  2. Ji S, Chueh HW, Kim JY, Lim SJ, Cho EJ, Lee SH, Yoo KH, Sung KW, Koo HH (2011) Responses and adverse effects of carboplatin-based chemotherapy for pediatric intracranial germ cell tumors. Korean J Pediatr 54:128–132

    Article  PubMed  CAS  Google Scholar 

  3. Alberts DS, Dorr RT (1998) New perspectives on an old friend: optimizing carboplatin for the treatment of solid tumors. Oncologist 3:15–34

    PubMed  CAS  Google Scholar 

  4. Goto Y, Sekine I, Tanioka M, Shibata T, Tanai C, Asahina H, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Kikkawa H, Ohki E, Tamura T (2011) Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer. Invest New Drugs. doi:10.1007/s10637-011-9715-4

  5. Yang X, Jin X, Song Q, Tang K, Yang Z, Zhang X, Tang Y (2010) Structural studies of dicycloplatin, an antitumor supramolecule. Sci China Chem 53:1346–1351

    Article  CAS  Google Scholar 

  6. Peng J, Wu H, Guan Z (2009) Chemotherapy-naive patients with advanced non-small-cell lung cancer-single institution experience. Chin J Clin Oncol 3:711–714

    Google Scholar 

  7. Wang C, Yan R (2005) Assay of the lung cancer cell apoptosis induced by dicycloplatin. J Practical Oncol 19:21–22

    Google Scholar 

  8. Yan D, Tu L, Peng X, Li W, Shen Z (2007) In vitro and in vivo antitumour activity of dicycloplatin, a new active platinum complex. Chin JMAP 24:352–356

    CAS  Google Scholar 

  9. Cao B, Chen X, Gu X, Wang G (2003) Pharmacokinetics of 0325k1-1 in dogs. J China Pharm Univ 34:369–371

    Google Scholar 

  10. Chen X, Liu X, Zhang G, Gu X, Meng H, Xin F, Li N, Wang G, Zhu J (2000) The pharmacokinetics of 0325k1-1 in rats. J China Pharm Univ 31:56–60

    Google Scholar 

  11. Villarino N, Cox S, Yarbrough J, Martín-Jiménez T (2010) Determination of carboplatin in canine plasma by high-performance liquid chromatography. Biomed Chromatogr 24:908–913

    PubMed  CAS  Google Scholar 

  12. Warren K, Gervais A, Aikin A, Egorin M, Balis FM (2004) Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors. Cancer Chemother Pharmacol 54:206–212

    Article  PubMed  CAS  Google Scholar 

  13. Delord JP, Umlil A, Guimbaud R, Grégoire N, Lafont T, Canal P, Bugat R, Chatelut E (2003) Population pharmacokinetics of oxaliplatin. Cancer Chemother Pharmacol 51:127–131

    PubMed  CAS  Google Scholar 

  14. Sova P, Mistr A, Kroutil A, Semerád M, Chlubnová H, Hrusková V, Chládková J, Chládek J (2011) A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis (acetato) amminedichloro(cyclohexylamine)platinum(IV). Cancer Chemother Pharmacol 67:1247–1256

    Article  PubMed  CAS  Google Scholar 

  15. Jacobs SS, Fox E, Dennie C, Morgan LB, McCully CL, Balis FM (2005) Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin Cancer Res 11:1669–1674

    Article  PubMed  CAS  Google Scholar 

  16. da Costa AC, Jr VMA, Luna AS, de Campos RC (2010) Determination of platinum originated from antitumoral drugs in human urine by atomic absorption spectrometric methods. Talanta 82:1647–1653

    Article  PubMed  Google Scholar 

  17. Stürup S (2004) The use of ICPMS for stable isotope tracer studies in humans: a review. Anal Bioanal Chem 378:273–282

    Article  PubMed  Google Scholar 

  18. Morrison JG, White P, McDougall S, Firth JW, Woolfrey SG, Graham MA, Greenslade D (2000) Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin. J Pharm Biomed Anal 24:1–10

    Article  PubMed  CAS  Google Scholar 

  19. Breda M, Maffini M, Mangia A, Mucchino C, Musci M (2008) Development and validation of an inductively coupled plasma mass spectrometry method with optimized microwave-assisted sample digestion for the determination of platinum at ultratrace levels in plasma and ultrafiltrate plasma. J Pharm Biomed Anal 48:435–439

    Article  PubMed  CAS  Google Scholar 

  20. Liu QF, Li X, Su Q, Luo GA, Wang YM, Liu WP (2009) Investigation on pharmacokinetics, tissue distribution and excretion of a novel anticancer platinum compound by inductively coupled plasma mass spectrometry after intravenous administration to rats. Arch Pharm Res 32:1621–1628

    Article  PubMed  CAS  Google Scholar 

  21. Brouwers EE, Tibben MM, Rosing H, Hillebrand MJ, Joerger M, Schellens JH, Beijnen JH (2006) Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate. J Mass Spectrom 41:1186–1194

    Article  PubMed  CAS  Google Scholar 

  22. Clerico A, Cappelli C, Ragni G, Caroli S, De Ioris MA, Sordi A, Petrucci F, Bocca B, Alimonti A (2006) Evaluation of carboplatin pharmacokinetics in pediatric oncology by means of inductively coupled plasma mass spectrometry. Ann Ist super Sanita 42:461–468

    PubMed  CAS  Google Scholar 

  23. Spezia S, Bocca B, Forte G, Gatti A, Mincione G, Ronchi A, Bavazzano P, Alimonti A, Minoia C (2005) Comparison of inductively coupled plasma mass spectrometry techniques in the determination of platinum in urine: quadrupole vs. sector field. Rapid Commun Mass Spectrom 19:1551–1556

    Article  PubMed  CAS  Google Scholar 

  24. Ghezzi A, Aceto M, Cassino C, Gabano E, Osella D (2004) Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS). J Inorq Biochem 98:73–78

    Article  CAS  Google Scholar 

  25. Siddik ZH, Newell DR, Boxall FE, Harrap KR (1987) The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. Biochem Pharmacol 36:1925–1932

    Article  PubMed  CAS  Google Scholar 

  26. Newell DR, Siddik ZH, Gumbrell LA, Boxall FE, Gore ME, Smith IE, Calvert AH (1987) Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin. Eur J Cancer Clin Oncol 23:1399–1405

    Article  PubMed  CAS  Google Scholar 

  27. Qin Z, Caruso JA, Lai B, Matusch A, Becker JS (2011) Trace metal imaging with high spatial resolution: applications in biomedicine. Metallomics 3:28–37

    Article  PubMed  CAS  Google Scholar 

  28. Su L, Mruk DD, Lee WM, Cheng CY (2011) Drug transporters and blood–testis barrier function. J Endocrinol 209:337–351

    Article  PubMed  CAS  Google Scholar 

  29. Liebner S, Czupalla CJ, Wolburg H (2011) Current concepts of blood–brain barrier development. Int J Dev Biol 55:467–476

    Article  PubMed  CAS  Google Scholar 

  30. Sterbis JR, Rice KR, Javitt MC, Schenkman NS, Brassell SA (2010) Fusion imaging: a novel staging modality in testis cancer. J Cancer 1:223–229

    Article  PubMed  Google Scholar 

  31. Schwaab T, Pili R (2011) Provenge: combating prostate cancer with a vengeance? Expert Rev Vaccines 10:1113–1114

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Jiangsu province Nanjing City Innovative Graduate Research Program (No.CXZZ11_0828).

Author information

Authors and Affiliations

  1. Center of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, 210009, Jiangsu, People’s Republic of China

    Di Zhao, Yongjie Zhang, Lingli Zhang, Cuiyun Li, Shuangxia Ren, Xin Wang, Shuoye Yang, Deen Han & Xijing Chen

  2. Jiangsu Product Quality Test & Inspect Institute, Nanjing, 210007, Jiangsu, People’s Republic of China

    Chunxiang Xu, Can Dong & Hui Lin

Authors
  1. Di Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yongjie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chunxiang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Can Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hui Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lingli Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cuiyun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shuangxia Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shuoye Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Deen Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xijing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xijing Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, D., Zhang, Y., Xu, C. et al. Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding Study of Platinum Originating from Dicycloplatin, a Novel Antitumor Supramolecule, in Rats and Dogs by ICP-MS. Biol Trace Elem Res 148, 203–208 (2012). https://doi.org/10.1007/s12011-012-9364-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-012-9364-2

Keywords

Search

Navigation